AP-1 blockade inhibits the growth of normal and malignant breast cells
Authors:
- Yongmin LiuYLYongmin Liu
- Debbie Muñoz-MedellinDMDebbie Muñoz-Medellin
- Susan G HilsenbeckSHSusan G Hilsenbeck
- Powel H BrownPowel H Brown
- 17 May 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (22) , 2771-2780
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 26 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Deficiencies in the Current Tax SystemThe Economic and Labour Relations Review, 1997
- Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometryCytometry, 1997
- AP-1 function and regulationCurrent Opinion in Cell Biology, 1997
- Activation and inhibition of the AP-1 complex in human breast cancer cellsMolecular Carcinogenesis, 1996
- A c-jun dominant negative mutant protects sympathetic neurons against programmed cell deathNeuron, 1995
- Systemic Gene Therapy with p53 Reduces Growth and Metastases of a Malignant Human Breast Cancer in Nude MiceHuman Gene Therapy, 1995
- Constitutive ap‐1 dna binding and transactivating ability of malignant but not benign mouse epidermal cellsMolecular Carcinogenesis, 1994
- Blockage of EGF Receptor Signal Transduction Causes Reversible Arrest of Normal and Immortal Human Mammary Epithelial Cells with Synchronous Reentry into the Cell CycleExperimental Cell Research, 1993
- The Molecular Genetics of CancerScience, 1987